Loading
A phase 3 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), leucovorin (folinic acid), gemcitabine and other drugs in pancreatic cancer, run by Fudan University, not yet recruiting.
HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT06217042 by Fudan University, with a registry enrolment figure of 524 participants, started 2024-02-05 and due to reach its primary completion in 2027-03-30. Interventions recorded: HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate; gemcitabine; capecitabine. Conditions listed: Pancreatic Cancer. Primary outcome: Disease-free survival (DFS). Pancreatic eligibility wording from the registry: "Histologically confirmed resected ductal pancreatic adenocarcinoma with macroscopic complete resection (R0 and R1)". Sites: China. No results are recorded here; the registry entry is the source.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Capecitabine and the tag pancreatic-deep-dive.